GSK may sell Horlicks to focus on OTC and oral health

The pharmaceuticals firm will take control of Sensodyne and Panadol from joint venture partner Novartis.

Comments

Popular posts from this blog

Giampiero Boniperti obituary

Newcastle’s transformation and reconnection testament to Howe’s coaching | Andy Brassell

Russian jets kill over 200 Islamic State militants near Syria's Deir al-Zor: agencies